Clinical Trial Update: Cemiplimab for Secondary Angiosarcomas [Phase 2]

View source ↗

Summary

This report indicates the completion of a Phase 2 trial evaluating cemiplimab for secondary angiosarcoma and related locally advanced or metastatic soft tissue …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Cemiplimab (Libtayo) (cemiplimab)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Secondary Angiosarcoma, Locally Advanced Sarcoma | Phase 2 | Status: COMPLETED